ClinConnect ClinConnect Logo
Search / Trial NCT06881121

IMPLICATION of FAST-TRACK PROTOCOL for HIP FRACTURE FIXATION in ALEXANDRIA UNIVERSITY HOSPITALS

Launched by ALEXANDRIA UNIVERSITY · Mar 9, 2025

Trial Information

Current as of May 09, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial, called the IMPLICATION study, is looking at how a fast-track protocol for fixing hip fractures affects patient outcomes. Specifically, it aims to find out if performing surgery within 48 hours of a hip fracture can help reduce the risk of death and other health problems in the month after surgery. Researchers will also be assessing issues like blood clots, breathing problems, memory issues after surgery, how long patients stay in the hospital or intensive care, and whether they need to be readmitted to the hospital.

To participate in this trial, individuals need to be at least 50 years old and have a specific level of physical health (classes I, II, or III). However, those with multiple injuries, certain medication sensitivities, or significant mental health issues, among other factors, will not be eligible. If you meet the criteria and join the study, you can expect to receive timely surgical care and thorough follow-up to monitor your recovery and any complications. This research could provide valuable insights into improving hip fracture treatment and recovery for older adults.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age ≥ 50 years.
  • 2. ASA physical status class I, II or III.
  • Exclusion Criteria:
  • 1. Poly-trauma patients.
  • 2. Patients with history of sensitivity to the studied drugs.
  • 3. Psychiatric disease or seizure disorder requiring medication within the previous 2 years.
  • 4. Opioid tolerant patients.
  • 5. Patients with preoperative cognitive dysfunction.

About Alexandria University

Alexandria University, a leading academic institution in Egypt, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise to conduct rigorous studies that address pressing health challenges. By fostering partnerships with healthcare professionals, industry leaders, and regulatory bodies, Alexandria University aims to contribute to the global body of medical knowledge and enhance the quality of patient care through evidence-based findings.

Locations

Alexandria, Egypt, Alexandria, Egypt

Patients applied

0 patients applied

Trial Officials

Moustafa Abdelaziz Ahmed, MD

Study Director

Alexandria University

Maher Doghiem, MD

Study Director

Alexandria University

Ahmed Shehab, MD

Study Director

Alexandria University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported